J. Hopwood

发表

Exocytosis is impaired in mucopolysaccharidosis IIIA mouse chromaffin cells

D. Brooks, J. Hopwood, K. Hemsley, 2012, Neuroscience.

Effect of high dose, repeated intra‐cerebrospinal fluid injection of sulphamidase on neuropathology in mucopolysaccharidosis type IIIA mice

K. Hemsley, H. Beard, B. King, 2008, Genes, brain, and behavior.

Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase

Zi-Fan Yu, Maurizio Scarpa, Paul Harmatz, 2010, Journal of Inherited Metabolic Disease.

Enzyme Replacement Therapy in Mucopolysaccharidosis I: Altered Distribution and Targeting of α-l-Iduronidase in Immunized Rats

D. Brooks, J. Hopwood, C. Turner, 2000 .

Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome.

D. Brooks, N. Fazzalari, J. Hopwood, 1996, The Journal of clinical investigation.

Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker.

P. Meikle, D. Brooks, L. Karageorgos, 1997, Clinical chemistry.

Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI.

J. Hopwood, S. Byers, E. L. Isaac, 1997, The Journal of clinical investigation.

Human N-acetylgalactosamine-4-sulphate sulphatase. Purification, monoclonal antibody production and native and subunit Mr values.

D. Brooks, J. Hopwood, G. Gibson, 1987, The Biochemical journal.

Identification of mutations in the alpha-L-iduronidase gene (IDUA) that cause Hurler and Scheie syndromes.

C. P. Morris, H. Scott, D. Brooks, 1993, American journal of human genetics.

Correction of mucopolysaccharidosis type I fibroblasts by retroviral-mediated transfer of the human alpha-L-iduronidase gene.

J. Hopwood, J. Bielicki, D. Anson, 1992, Human gene therapy.